If you have been reading about modified GRF(1-29) and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (with DAC) | ~3647 Da | Calculated from the full amino acid sequence |
| Molecular weight (without DAC) | ~3368 Da | Mod GRF(1-29) variant |
| Appearance | White lyophilized powder | Typical form supplied for research |
| Solubility | Soluble in water | Dissolves in aqueous buffers |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
=== BP Deepwater Horizon Research === In 2015 Cave won second place in the Intel International Science and Engineering Fair in the Earth & Environmental Sciences Category with her research on the BP Oil Spill impact. As a result, NASA and MIT Lincoln Laboratory renamed minor planet "2000 GD136" after her. She began her research at the University of New Orleans at 15, funded by GOMRI (Gulf of Mexico Research Initiative). The research, titled "A Method for Identifying the Photoproducts, Mechanisms, and Toxicity of Petroleum from the Deepwater Horizon by High-Performance Liquid Chromatography and DNPHi Derivatization," provided a method for the U.S. Environmental Protection Agency to identify nanotoxins that form in seawater after oil spills. Cave's method later became a spinoff project in Ecology and Evolutionary Biology conducted at Tulane University in 2016. During this time, Cave traveled with her lab to Gamboa, Panama to conduct research with the Smithsonian Tropical Research Institute.
The myosin-binding protein C, cardiac-type is a protein that in humans is encoded by the MYBPC3 gene. This isoform is expressed exclusively in heart muscle during human and mouse development, and is distinct from those expressed in slow skeletal muscle (MYBPC1) and fast skeletal muscle (MYBPC2).
buffered solution Also simply called a buffer. An aqueous solution consisting of a weak acid and its conjugate base or a weak base and its conjugate acid that resists changes in pH when strong acids or bases are added.
== Chemical mechanism == An important goal of measuring enzyme kinetics is to determine the chemical mechanism of an enzyme reaction, i.e., the sequence of chemical steps that transform substrate into product. The kinetic approaches discussed above will show at what rates intermediates are formed and inter-converted, but they cannot identify exactly what these intermediates are. Kinetic measurements taken under various solution conditions or on slightly modified enzymes or substrates often shed light on this chemical mechanism, as they reveal the rate-determining step or intermediates in the reaction. For example, the breaking of a covalent bond to a hydrogen atom is a common rate-determining step. Which of the possible hydrogen transfers is rate determining can be shown by measuring the kinetic effects of substituting each hydrogen by deuterium, its stable isotope. The rate will change when the critical hydrogen is replaced, due to a primary kinetic isotope effect, which occurs because bonds to deuterium are harder to break than bonds to hydrogen. It is also possible to measure similar effects with other isotope substitutions, such as 13C/12C and 18O/16O, but these effects are more subtle. Isotopes can also be used to reveal the fate of various parts of the substrate molecules in the final products. For example, it is sometimes difficult to discern the origin of an oxygen atom in the final product, since it may have come from water or from part of the substrate.
Sources: en.wikipedia.org
The computer failed on the 48th revolution when McDivitt tried to update it for reentry. It would not turn off and eventually stopped working altogether. This was unfortunate for IBM, which had just put an advertisement suggesting that its computers were so reliable that even NASA used them. The computer failure meant that the capsule would not be able to perform a closed-loop lifting reentry as planned. IBM were unable to duplicate the failure on the ground but they installed a manual override switch on subsequent Gemini missions. It was the only Gemini mission to experience a computer failure. Reentry came on the 62nd revolution. An open-loop rolling reentry (as used in Mercury) had to be used because of the computer failure. The astronauts began rolling the spacecraft at 120 kilometers (75 mi; 65 nmi) altitude to increase its stability. They started slowing the roll rate at 27,000 meters (89,000 ft) and stopped it by 12,000 meters (39,000 ft). The drogue parachute deployed shortly after this, and the main deployed at 3,200 meters (10,600 ft). A malfunctioning thruster caused the roll to be much faster than planned, and the landing was rough. Despite the rough landing, neither of the crew encountered any problems, contrary to NASA doctors' concerns about their landing upright – as opposed to on their backs, as in Mercury – after four days in space. Even though they landed 80 km (50 mi; 43 nmi) short of the intended landing target, some ships had already started steaming to the touchdown point, and a helicopter was able to see them land.
A set of nuclides with equal proton number (atomic number), i.e., of the same chemical element but different neutron numbers, are called isotopes of the element. Particular nuclides are still often loosely called "isotopes", but the term "nuclide" is now considered the correct one in the general case when no specific element (Z value) encompasses them. In similar manner, a set of nuclides with equal mass number A, but different atomic number, are called isobars (isobar = equal in weight), and isotones are nuclides of equal neutron number but different proton numbers. Likewise, nuclides with the same neutron excess (N − Z) are called isodiaphers. The name isotone was derived from the name isotope to emphasize that in the first group of nuclides it is the number of neutrons (n) that is constant, whereas in the second the number of protons (p). See Isotope#Notation for an explanation of the notation used for different nuclide or isotope types. Nuclear isomers are members of a set of nuclides with equal proton number and equal mass number (thus making them by definition the same isotope), but different states of excitation. An example is the two states of the single isotope 9943Tc shown among the decay schemes. Each of these two states (technetium-99m and technetium-99) qualifies as a different nuclide, illustrating one way that nuclides may differ from isotopes (an isotope may consist of several different nuclides of different excitation states).
=== Saudi Arabia === Galloway has criticised Britain's close ties with Saudi Arabia and British involvement in the Saudi Arabian-led intervention in Yemen. In 2017, he said: "It is a country with no democracy or freedom of any kind. It is a country that exports terrorism around the world and funds terrorism and extremism around the world. We should have nothing whatsoever to do with them."
Sources: en.wikipedia.org
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.
The maleimide group forms a covalent link with albumin, an abundant blood protein. This attachment slows clearance, so a single administration persists much longer than the unmodified peptide. The feature is the main reason the two variants are handled differently in study design.
It is not an approved therapeutic product in major regulatory jurisdictions. It appears in research chemical catalogs and scientific literature rather than pharmacy shelves. Clinical development was limited and did not reach approval.
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.